View in EDS

Immune checkpoint inhibitor-induced eosinophilic fasciitis: A pharmacovigilance and EADV Task force study.

Saved in:
Bibliographic Details
Title: Immune checkpoint inhibitor-induced eosinophilic fasciitis: A pharmacovigilance and EADV Task force study.
Authors: Bruijn TVM; Department of Dermatology, Amsterdam UMC, Amsterdam, The Netherlands.; Department of Dermatology, The Netherlands Cancer Institute-Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Gérard AO; Department of Clinical Pharmacology, Université Côte d'Azur, University Hospital Centre of Nice, Nice, France.; Laboratory of Molecular Physio Medicine (LP2M), UMR 7370, CNRS, Université Côte d'Azur, Nice, France., Labat M; Saint Louis Régional Pharmacovigilance Centre, Clinical Investigation Centre (INSERM CIC 1427), Saint-Louis Hospital, Paris, France., Apalla Z; Second Dermatology Department, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece., Binsbergen WV; Department of Rheumatology & Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands., Koumaki D; Dermatology Department, University Hospital of Heraklion, Crete, Greece., Rivet V; Internal Medicine and Immunopathology Department, The Cancer University of Toulouse Oncopole, Toulouse University Hospital, Toulouse, France., Dezoteux F; Service de Dermatologie, Hôpital Claude-Huriez, Université de Lille, INFINITE Institute for Translational Research in Inflammation, Lille, France., Giacchero D; Oncology Departement, Centre Antoine Lacassagne, Nice, France., Ardern-Jones MR; Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Department of Dermatology, University Hospitals Southampton NHS Foundation Trust, Southampton, UK., Heelan K; The Royal Marsden Foundation Trust, London, UK., Hirner JP; Department of Dermatology, University of Nebraska, Omaha, Nebraska, USA., Mayor A; Servicio de Dermatología, Hospital Universitario La Paz, Madrid, Spain., Labots M; Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, The Netherlands., Starink MV; Department of Dermatology, Amsterdam UMC, Amsterdam, The Netherlands., Laken CJV; Department of Rheumatology & Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands., Sibaud V; Department of Oncodermatology, Oncopole Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France., Elshot YS; Department of Dermatology, Amsterdam UMC, Amsterdam, The Netherlands.; Department of Dermatology, The Netherlands Cancer Institute-Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
Source: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2026 Jun 08. Date of Electronic Publication: 2026 Jun 08.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42253044
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immune checkpoint inhibitor-induced eosinophilic fasciitis: A pharmacovigilance and EADV Task force study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bruijn+TVM%22">Bruijn TVM</searchLink>; Department of Dermatology, Amsterdam UMC, Amsterdam, The Netherlands.; Department of Dermatology, The Netherlands Cancer Institute-Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gérard+AO%22">Gérard AO</searchLink>; Department of Clinical Pharmacology, Université Côte d'Azur, University Hospital Centre of Nice, Nice, France.; Laboratory of Molecular Physio Medicine (LP2M), UMR 7370, CNRS, Université Côte d'Azur, Nice, France.<br /><searchLink fieldCode="AU" term="%22Labat+M%22">Labat M</searchLink>; Saint Louis Régional Pharmacovigilance Centre, Clinical Investigation Centre (INSERM CIC 1427), Saint-Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Apalla+Z%22">Apalla Z</searchLink>; Second Dermatology Department, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Binsbergen+WV%22">Binsbergen WV</searchLink>; Department of Rheumatology & Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Koumaki+D%22">Koumaki D</searchLink>; Dermatology Department, University Hospital of Heraklion, Crete, Greece.<br /><searchLink fieldCode="AU" term="%22Rivet+V%22">Rivet V</searchLink>; Internal Medicine and Immunopathology Department, The Cancer University of Toulouse Oncopole, Toulouse University Hospital, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Dezoteux+F%22">Dezoteux F</searchLink>; Service de Dermatologie, Hôpital Claude-Huriez, Université de Lille, INFINITE Institute for Translational Research in Inflammation, Lille, France.<br /><searchLink fieldCode="AU" term="%22Giacchero+D%22">Giacchero D</searchLink>; Oncology Departement, Centre Antoine Lacassagne, Nice, France.<br /><searchLink fieldCode="AU" term="%22Ardern-Jones+MR%22">Ardern-Jones MR</searchLink>; Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Department of Dermatology, University Hospitals Southampton NHS Foundation Trust, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Heelan+K%22">Heelan K</searchLink>; The Royal Marsden Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Hirner+JP%22">Hirner JP</searchLink>; Department of Dermatology, University of Nebraska, Omaha, Nebraska, USA.<br /><searchLink fieldCode="AU" term="%22Mayor+A%22">Mayor A</searchLink>; Servicio de Dermatología, Hospital Universitario La Paz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Labots+M%22">Labots M</searchLink>; Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Starink+MV%22">Starink MV</searchLink>; Department of Dermatology, Amsterdam UMC, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Laken+CJV%22">Laken CJV</searchLink>; Department of Rheumatology & Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Sibaud+V%22">Sibaud V</searchLink>; Department of Oncodermatology, Oncopole Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Elshot+YS%22">Elshot YS</searchLink>; Department of Dermatology, Amsterdam UMC, Amsterdam, The Netherlands.; Department of Dermatology, The Netherlands Cancer Institute-Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229216037%22">Journal of the European Academy of Dermatology and Venereology : JEADV</searchLink> [J Eur Acad Dermatol Venereol] 2026 Jun 08. <i>Date of Electronic Publication: </i>2026 Jun 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9216037 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-3083 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209269959%22">09269959 </searchLink><i>NLM ISO Abbreviation: </i>J Eur Acad Dermatol Venereol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42253044
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/jdv.70512
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Immune checkpoint inhibitor-induced eosinophilic fasciitis: A pharmacovigilance and EADV Task force study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bruijn TVM
      – PersonEntity:
          Name:
            NameFull: Gérard AO
      – PersonEntity:
          Name:
            NameFull: Labat M
      – PersonEntity:
          Name:
            NameFull: Apalla Z
      – PersonEntity:
          Name:
            NameFull: Binsbergen WV
      – PersonEntity:
          Name:
            NameFull: Koumaki D
      – PersonEntity:
          Name:
            NameFull: Rivet V
      – PersonEntity:
          Name:
            NameFull: Dezoteux F
      – PersonEntity:
          Name:
            NameFull: Giacchero D
      – PersonEntity:
          Name:
            NameFull: Ardern-Jones MR
      – PersonEntity:
          Name:
            NameFull: Heelan K
      – PersonEntity:
          Name:
            NameFull: Hirner JP
      – PersonEntity:
          Name:
            NameFull: Mayor A
      – PersonEntity:
          Name:
            NameFull: Labots M
      – PersonEntity:
          Name:
            NameFull: Starink MV
      – PersonEntity:
          Name:
            NameFull: Laken CJV
      – PersonEntity:
          Name:
            NameFull: Sibaud V
      – PersonEntity:
          Name:
            NameFull: Elshot YS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 06
              Text: 2026 Jun 08
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1468-3083
          Titles:
            – TitleFull: Journal of the European Academy of Dermatology and Venereology : JEADV
              Type: main
ResultId 1